C. Marcelo Sergio

2.5k total citations
21 papers, 1.1k citations indexed

About

C. Marcelo Sergio is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, C. Marcelo Sergio has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in C. Marcelo Sergio's work include Cancer-related Molecular Pathways (12 papers), Estrogen and related hormone effects (7 papers) and DNA Repair Mechanisms (3 papers). C. Marcelo Sergio is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Estrogen and related hormone effects (7 papers) and DNA Repair Mechanisms (3 papers). C. Marcelo Sergio collaborates with scholars based in Australia, United Kingdom and United States. C. Marcelo Sergio's co-authors include Elizabeth A. Musgrove, Robert L. Sutherland, Jason S. Carroll, C. Elizabeth Caldon, Sophie Doisneau-Sixou, Rina Hui, R. Sutherland, Jian Kang, Chris J. Mitchell and Boris Šarčević and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

C. Marcelo Sergio

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Marcelo Sergio Australia 16 703 486 281 250 207 21 1.1k
Teeru Bihani United States 14 530 0.8× 388 0.8× 305 1.1× 210 0.8× 353 1.7× 27 1.1k
Matthew H. Herynk United States 17 799 1.1× 613 1.3× 525 1.9× 379 1.5× 407 2.0× 24 1.5k
Demetra Constantinidou United Kingdom 5 1.1k 1.5× 495 1.0× 444 1.6× 188 0.8× 176 0.9× 6 1.4k
Hirokazu Kurokawa Japan 13 511 0.7× 555 1.1× 287 1.0× 154 0.6× 105 0.5× 29 913
Christine S. L. Lee Australia 18 636 0.9× 709 1.5× 506 1.8× 236 0.9× 118 0.6× 19 1.2k
Cecilia J. Proietti Argentina 22 691 1.0× 689 1.4× 327 1.2× 298 1.2× 97 0.5× 37 1.3k
Marie Will United States 8 710 1.0× 554 1.1× 364 1.3× 448 1.8× 467 2.3× 14 1.5k
Yu-Mei Feng China 21 847 1.2× 466 1.0× 83 0.3× 383 1.5× 146 0.7× 41 1.3k
Claus Lattrich Germany 18 355 0.5× 508 1.0× 379 1.3× 328 1.3× 152 0.7× 49 1.1k
Xiao-Feng Le United States 21 910 1.3× 462 1.0× 105 0.4× 274 1.1× 92 0.4× 23 1.3k

Countries citing papers authored by C. Marcelo Sergio

Since Specialization
Citations

This map shows the geographic impact of C. Marcelo Sergio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Marcelo Sergio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Marcelo Sergio more than expected).

Fields of papers citing papers by C. Marcelo Sergio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Marcelo Sergio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Marcelo Sergio. The network helps show where C. Marcelo Sergio may publish in the future.

Co-authorship network of co-authors of C. Marcelo Sergio

This figure shows the co-authorship network connecting the top 25 collaborators of C. Marcelo Sergio. A scholar is included among the top collaborators of C. Marcelo Sergio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Marcelo Sergio. C. Marcelo Sergio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhattacharyya, Nayan D., Wunna Kyaw, Michelle M. McDonald, et al.. (2023). Minimally invasive longitudinal intravital imaging of cellular dynamics in intact long bone. Nature Protocols. 18(12). 3856–3880. 6 indexed citations
2.
Portman, Neil, Kristine J. Fernandez, Christine U. Lee, et al.. (2021). Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition. npj Breast Cancer. 7(1). 111–111. 15 indexed citations
3.
Lee, Christine U., Kristine J. Fernandez, Sarah Alexandrou, et al.. (2020). Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer. Cancers. 12(8). 2268–2268. 18 indexed citations
4.
Pacchiarotti, Arianna, et al.. (2020). Severe endometriosis: low value of AMH did not affect oocyte quality and pregnancy outcome in IVF patients.. PubMed. 24(22). 11488–11495. 8 indexed citations
5.
Rogers, Samuel, Brian Gloss, C. Marcelo Sergio, et al.. (2015). Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells. Cell Division. 10(1). 1–1. 19 indexed citations
6.
Kang, Jian, C. Marcelo Sergio, Robert L. Sutherland, & Elizabeth A. Musgrove. (2014). Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells. BMC Cancer. 14(1). 32–32. 114 indexed citations
7.
Stone, Andrew, Mark J. Cowley, Fátima Valdés‐Mora, et al.. (2013). BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer. Molecular Cancer Therapeutics. 12(9). 1874–1885. 39 indexed citations
8.
Caldon, C. Elizabeth, C. Marcelo Sergio, Robert L. Sutherland, & Elizabeth A. Musgrove. (2013). Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells. Cell Cycle. 12(4). 596–605. 19 indexed citations
9.
Caldon, C. Elizabeth, C. Marcelo Sergio, Andrew Burgess, et al.. (2013). Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1. Cell Cycle. 12(4). 606–617. 33 indexed citations
10.
Caldon, C. Elizabeth, C. Marcelo Sergio, Jian Kang, et al.. (2012). Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells. Molecular Cancer Therapeutics. 11(7). 1488–1499. 125 indexed citations
11.
Caldon, C. Elizabeth, C. Marcelo Sergio, Judith Schütte, et al.. (2009). Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc. Molecular and Cellular Biology. 29(17). 4623–4639. 59 indexed citations
12.
Musgrove, Elizabeth A., C. Marcelo Sergio, Claire K. Inman, et al.. (2008). Identification of Downstream Targets of Estrogen and c-myc in Breast Cancer Cells. Advances in experimental medicine and biology. 617. 445–451. 10 indexed citations
13.
Butt, Alison J., C. Marcelo Sergio, Claire K. Inman, et al.. (2008). The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome. Breast Cancer Research. 10(2). R28–R28. 28 indexed citations
14.
Musgrove, Elizabeth A., C. Marcelo Sergio, Sherene Loi, et al.. (2008). Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer. PLoS ONE. 3(8). e2987–e2987. 87 indexed citations
15.
McGowan, Eileen, Amanda J. Russell, Viroj Boonyaratanakornkit, et al.. (2007). Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor. Cancer Research. 67(18). 8942–8951. 29 indexed citations
16.
McNeil, Catriona M., C. Marcelo Sergio, Claire K. Inman, et al.. (2006). c-Myc overexpression and endocrine resistance in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 102(1-5). 147–155. 70 indexed citations
17.
Mawson, Amanda, Angela Lai, Jason S. Carroll, et al.. (2004). Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Molecular and Cellular Endocrinology. 229(1-2). 161–173. 97 indexed citations
18.
Swarbrick, Alexander, Mia C. Åkerfeldt, Christine S. L. Lee, et al.. (2004). Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix–loop–helix protein Id1. Oncogene. 24(3). 381–389. 56 indexed citations
19.
Doisneau-Sixou, Sophie, C. Marcelo Sergio, Jason S. Carroll, et al.. (2003). Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.. Endocrine Related Cancer. 10(2). 179–186. 262 indexed citations
20.
Doisneau-Sixou, Sophie, C. Marcelo Sergio, Jason S. Carroll, et al.. (2003). International Congress on Hormonal Steroids and Hormones and Cancer Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teeru Bihani Breakdown of academic impact, for papers by Matthew H. Herynk Breakdown of academic impact, for papers by Demetra Constantinidou Breakdown of academic impact, for papers by Hirokazu Kurokawa Breakdown of academic impact, for papers by Christine S. L. Lee Breakdown of academic impact, for papers by Cecilia J. Proietti Breakdown of academic impact, for papers by Marie Will Breakdown of academic impact, for papers by Yu-Mei Feng Breakdown of academic impact, for papers by Claus Lattrich Breakdown of academic impact, for papers by Xiao-Feng Le
Rankless by CCL
2026